[go: up one dir, main page]

DK219083A - Fremgangsmaade til fremstilling af en sesquiterpenlaktonholdig ekstrakt - Google Patents

Fremgangsmaade til fremstilling af en sesquiterpenlaktonholdig ekstrakt Download PDF

Info

Publication number
DK219083A
DK219083A DK219083A DK219083A DK219083A DK 219083 A DK219083 A DK 219083A DK 219083 A DK219083 A DK 219083A DK 219083 A DK219083 A DK 219083A DK 219083 A DK219083 A DK 219083A
Authority
DK
Denmark
Prior art keywords
lactaining
sesquiter
pen
extract
procedure
Prior art date
Application number
DK219083A
Other languages
English (en)
Other versions
DK219083D0 (da
Inventor
Edward Stewart Johnson
Peter John Hylands
Deborah Margaret Hylands
Original Assignee
Edward Stewart Johnson
Peter John Hylands
Deborah Margaret Hylands
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26282867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK219083(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Edward Stewart Johnson, Peter John Hylands, Deborah Margaret Hylands filed Critical Edward Stewart Johnson
Publication of DK219083D0 publication Critical patent/DK219083D0/da
Publication of DK219083A publication Critical patent/DK219083A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK219083A 1982-05-19 1983-05-17 Fremgangsmaade til fremstilling af en sesquiterpenlaktonholdig ekstrakt DK219083A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8214572 1982-05-19
GB8227062 1982-09-22

Publications (2)

Publication Number Publication Date
DK219083D0 DK219083D0 (da) 1983-05-17
DK219083A true DK219083A (da) 1983-11-20

Family

ID=26282867

Family Applications (1)

Application Number Title Priority Date Filing Date
DK219083A DK219083A (da) 1982-05-19 1983-05-17 Fremgangsmaade til fremstilling af en sesquiterpenlaktonholdig ekstrakt

Country Status (13)

Country Link
US (1) US4758433A (da)
EP (1) EP0098041B1 (da)
KR (1) KR840004511A (da)
AR (1) AR230008A1 (da)
AU (1) AU564371B2 (da)
CA (1) CA1270843A (da)
DE (1) DE3380306D1 (da)
DK (1) DK219083A (da)
FI (1) FI831740L (da)
GB (1) GB2124486B (da)
IE (1) IE55766B1 (da)
NO (1) NO831762L (da)
NZ (1) NZ204256A (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3635522A1 (de) * 1986-10-18 1988-04-28 Euro Celtique Sa Pharmazeutische zusammensetzung
EP0364442B1 (en) * 1987-12-23 1993-03-03 Psoricur Ltd. Therapeutical compositions against psoriasis
GB9100581D0 (en) * 1991-01-11 1991-02-27 Rhodes Technology Method for the extraction of sesquiterpene lactones
DE4202657C2 (de) * 1992-01-31 1995-10-12 Schaper & Bruemmer Gmbh Pharmazeutisch wirksame Zusammensetzung aus Tanacetum parthenium sowie Verfahren zu deren Extraktion und mit der pharmazeutisch wirksamen Zusammensetzung hergestelltes Arzneimittel
US5576329A (en) * 1992-07-24 1996-11-19 Hennessey; Richard K. Method for treating tendon or joint inflammation with papaverine HCL
US5278172A (en) * 1992-07-24 1994-01-11 Hennessey Richard K Method and composition for treating tendon or joint inflammation using a vasodilator
CN1056142C (zh) * 1993-01-04 2000-09-06 昆明医学院第一附属医院 水朝阳内酯的制备方法
CA2141126A1 (en) * 1995-01-26 1996-07-27 Natalie J. Lazarowych Combinational drug for treating migraine and other illnesses
US6379714B1 (en) 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
US5665731A (en) * 1995-06-07 1997-09-09 Hennessey; Richard K. Method and composition for treating with a vasodilator inflammation, bone loss and detachment of teeth as associated with periodontal
AU711019B2 (en) 1996-10-21 1999-10-07 Eurovita A/S Pharmaceutical compositions containing parthenium integrifolium or parts thereof or an extract or component thereof, the use of such plant material for preparing certain medicines, and a method of preparing an extract of parthenium integrifolium
US5905089A (en) * 1997-04-14 1999-05-18 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Use of sesquiterpene lactones for treatment of severe inflammatory disorders
US5972916A (en) * 1997-07-14 1999-10-26 Bristol-Myers Squibb Company Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine
AU1573499A (en) * 1997-12-23 1999-07-19 Moser, Rene Sesquiterpene lactones specifically inhibit activation of nf-k B by preventing the degradation of IkB-alpha and IkB-beta
US6225339B1 (en) * 1998-01-29 2001-05-01 Pfizer Inc. Terpenoid lactone compounds and their production process
US6068999A (en) * 1998-06-25 2000-05-30 Hendrix; Curt Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
US6221899B1 (en) 1999-01-15 2001-04-24 Pfizer Inc. Terpenoid lactone compounds and their production process
JP2004500329A (ja) * 1999-06-03 2004-01-08 ジョンソン・アンド・ジョンソン・コンシューマー・フランス・エスアーエス 炎症性異常症状に適応するナツシロギク（タナセタム・パルテニウム）の抽出物
US20030003170A1 (en) * 2000-06-02 2003-01-02 Theresa Callaghan Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
IT1312342B1 (it) 1999-06-03 2002-04-15 Indena Spa Estratto di tanacetum parthenium sostanzialmente privo di gammalattoni-alfa-insaturi.
US6642243B1 (en) 1999-07-22 2003-11-04 Ashkan Imanzahrai Migraine medicine and method for treating same
DE10015617A1 (de) * 2000-03-29 2001-10-04 Peter Laetzsch Migränemittel
IN188857B (da) * 2000-07-14 2002-11-16 Govind Kane Dr Shantaram
US20030077343A1 (en) * 2001-03-16 2003-04-24 Martin Katharine M. Composition containing feverfew extract and use thereof
CA2441025C (en) * 2001-03-16 2011-08-16 Johnson & Johnson Consumer Companies, Inc. Composition containing feverfew extract and use thereof
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040086579A1 (en) * 2002-11-05 2004-05-06 Higgins James W. Dietary supplement comprising parthenolide
US20040219229A1 (en) * 2003-04-30 2004-11-04 Tim Clarot Migraine relief composition and methods of using and forming same
US20040247706A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal dietary supplement comprising parthenolide
US20040247705A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US7678904B2 (en) 2003-07-11 2010-03-16 University Of Kentucky Use of parthenolide derivatives as antileukemic and cytotoxic agents
US20050186269A1 (en) * 2004-02-25 2005-08-25 Udell Ronald G. Stabilized feverfew formulations
US20060222722A1 (en) * 2005-03-30 2006-10-05 Roberts Stephen C Sublingual methods of treatment to alleviate or prevent arthritis
WO2008157833A1 (en) * 2007-06-21 2008-12-24 Puramed Bioscience Inc. Compositions and methods for treating and preventing migrainous headaches and associated symptoms
US10500182B2 (en) * 2018-01-10 2019-12-10 Robert Firger Compositions of ketogenic sources, micronutrients and phytochemicals for prophylaxis and mitigation of migraine headache
CN109761994B (zh) * 2019-02-28 2021-06-29 中国科学院新疆理化技术研究所 降碳类愈创木烷型倍半萜内酯类化合物及其制备方法

Also Published As

Publication number Publication date
AR230008A1 (es) 1984-02-29
DE3380306D1 (en) 1989-09-07
EP0098041B1 (en) 1989-08-02
EP0098041A2 (en) 1984-01-11
AU1464683A (en) 1983-11-24
IE55766B1 (en) 1991-01-16
NZ204256A (en) 1988-02-29
FI831740A0 (fi) 1983-05-18
US4758433A (en) 1988-07-19
EP0098041A3 (en) 1984-12-12
DK219083D0 (da) 1983-05-17
GB2124486B (en) 1986-07-16
GB2124486A (en) 1984-02-22
NO831762L (no) 1983-11-21
AU564371B2 (en) 1987-08-13
KR840004511A (ko) 1984-10-22
FI831740L (fi) 1983-11-20
IE831164L (en) 1983-11-19
CA1270843A (en) 1990-06-26
GB8313530D0 (en) 1983-06-22

Similar Documents

Publication Publication Date Title
DK219083A (da) Fremgangsmaade til fremstilling af en sesquiterpenlaktonholdig ekstrakt
DK1183D0 (da) Fremgangsmade til fremstilling af tiazolidinderivater
DK158282C (da) Fremgangsmaade til fremstilling af et fast fibrinogenpraeparat
DK350083D0 (da) Fremgangsmade til fremstilling af phenylethanolaminer
DK343581A (da) Fremgangsmaade til fremstilling af et triamterenpraeparat
DK522081A (da) Fremgangsmaade til fremstilling af xanthater
DK372283D0 (da) Fremgangsmade til fremstilling af desoxyuridinderivater
DK1584A (da) Fremgangsmaade til fremstilling af et gitterkernesandwichelement
DK309783D0 (da) Fremgangsmade til fremstilling af organoglykosider
DK299483D0 (da) Fremgangsmade til fremstilling af n-phosphonomethylglycin
DK119083D0 (da) Fremgangsmade til fremstilling af alkanoylpyridinoner
DK283083D0 (da) Fremgangsmade til fremstilling af n-phosphonomethylglycin
DK226379A (da) Fremgangsmaade til fremstilling af harpikser
DK451883D0 (da) Fremgangsmade til fremstilling af 4-methyl-5-alkylthiometyl-imidazoler
DK152043C (da) Fremgangsmaade til fremstilling af et ranitidin
DK424083A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK296383D0 (da) Fremgangsmade til fremstilling af fenaetylaminer
DK394783A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK361983A (da) Fremgangsmaade til fremstilling af meldroejealkaloider
DK62283D0 (da) Fremgangsmade til fremstilling af peptidergotalkaloider
DK219483A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK385983D0 (da) Fremgangsmade til fremstilling af 1-oxacephamer
DK9383A (da) Fremgangsmaade til fremstilling af phosphinoxider
DK10883A (da) Fremgangsmaade til fremstilling af substituerede chloracetanilider
DK96383A (da) Fremgangsmaade til fremstilling af 3-azetidinylaetyl-1-fenyl-2-imidazolidinonderivater

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment